- Home
- MCR vs BWAY Comparison
MCR vs BWAY Comparison
Compare MCR & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCR
- BWAY
- Stock Information
- Founded
- MCR 1989
- BWAY 2003
- Country
- MCR United States
- BWAY Israel
- Employees
- MCR N/A
- BWAY N/A
- Industry
- MCR Trusts Except Educational Religious and Charitable
- BWAY Medical/Dental Instruments
- Sector
- MCR Finance
- BWAY Health Care
- Exchange
- MCR Nasdaq
- BWAY Nasdaq
- Market Cap
- MCR 263.1M
- BWAY 280.7M
- IPO Year
- MCR N/A
- BWAY 2019
- Fundamental
- Price
- MCR $6.35
- BWAY $15.55
- Analyst Decision
- MCR
- BWAY Strong Buy
- Analyst Count
- MCR 0
- BWAY 2
- Target Price
- MCR N/A
- BWAY $18.00
- AVG Volume (30 Days)
- MCR 66.7K
- BWAY 70.1K
- Earning Date
- MCR 01-01-0001
- BWAY 11-11-2025
- Dividend Yield
- MCR 8.52%
- BWAY N/A
- EPS Growth
- MCR N/A
- BWAY 679.98
- EPS
- MCR 0.38
- BWAY 0.11
- Revenue
- MCR N/A
- BWAY $46,084,000.00
- Revenue This Year
- MCR N/A
- BWAY $335.63
- Revenue Next Year
- MCR N/A
- BWAY $22.10
- P/E Ratio
- MCR $16.61
- BWAY $56.52
- Revenue Growth
- MCR N/A
- BWAY 26.50
- 52 Week Low
- MCR $5.63
- BWAY $7.84
- 52 Week High
- MCR $6.70
- BWAY $17.92
- Technical
- Relative Strength Index (RSI)
- MCR 45.49
- BWAY 42.72
- Support Level
- MCR $6.28
- BWAY $16.65
- Resistance Level
- MCR $6.38
- BWAY $17.92
- Average True Range (ATR)
- MCR 0.07
- BWAY 0.63
- MACD
- MCR 0.00
- BWAY -0.16
- Stochastic Oscillator
- MCR 30.00
- BWAY 13.38
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.